GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2576 - 2600 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 1 22 moderate
G94435QH
364
IgA Patient 1 6 moderate
G00048MO
364
IgM Patient 1 22 moderate
G81315DD
364
IgA Patient 2 15 mild
G47566FL
364
IgM Patient 2 24 mild
G98240FC
364
IgA Patient 3 11 mild
G82779CI
364
IgA Patient 3 4 mild
G00054MO
364
IgA Patient 1 6 moderate
G00057MO
365
IgA Patient 2 15 mild
G38488WF
365
IgA Patient 2 24 mild
G17266GE
365
IgG Patient 4 12 mild
G75896PD
365
IgA Patient 1 10 moderate
G18057VI
366
IgA Patient 1 22 moderate
G40696TO
366
IgA Patient 2 3 mild
G17689EW
366
IgA Patient 2 3 mild
G38488WF
366
IgA Patient 3 4 mild
G40696TO
366
IgA Patient 1 10 moderate
G00051MO
367
IgA Patient 1 10 moderate
G68461PT
367
IgA Patient 3 11 mild
G62826CL
367
IgA Patient 3 4 mild
G17390SF
367
IgA Patient 4 12 mild
G41200QS
367
IgA Patient 1 10 moderate
G22768VO
368
IgA Patient 1 22 moderate
G66937TJ
368
IgA Patient 2 24 mild
G14844CX
368
IgA Patient 2 24 mild
G62222PE
368

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024